A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Stanford University (Data Collection AND Specimen Analysis), Stanford, California, United States

    Contact: Study coordinator (Lori Muffly, MD) · 650-498-6000
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Ioannis Kalogirou Valtis, MD) · 646-608-2091
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Ioannis Kalogirou Valtis, MD) · 646-608-2091
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Ioannis Kalogirou Valtis, MD) · 646-608-2091
  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Ioannis Kalogirou Valtis, MD) · 646-608-2091
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Ioannis Kalogirou Valtis, MD) · 646-608-2091
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Ioannis Kalogirou Valtis, MD) · 646-608-2091
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Ioannis Kalogirou Valtis, MD) · 646-608-2091
Study leads
  • Ioannis Kalogirou Valtis, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center